Needham Reiterates a Buy Rating on Autolus Therapeutics (AUTL), Keeps the PT at $10
Autolus Therapeutics plc (NASDAQ:AUTL) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. Analyst Gil Blum from Needham reiterated a Buy rating on Autolus Therapeutics plc (NASDAQ:AUTL) on June 12, keeping the price target at $10.00.
The analyst cited the promising results of the FELIX study for obe-cel in patients with relapsed/refractory acute lymphoblastic leukemia (ALL) as one of the factors supporting the optimistic rating, stating that the updated analysis highlights a notable number of patients in remission with no need for further therapy. This is a positive indicator, according to the analyst, especially in comparison to other treatments such as Tecartus.
A laboratory technician carefully studying a microscope with a biopharmaceutical product inside.
While the analyst acknowledged that 38% of responders were still in remission with a median follow-up of 33 months, a slight drop from the 40% reported at 21.5 months, he stated that the results are still impressive. He also cited other promising factors, including the overall survival and event-free survival rates, as well as the absence of new safety concerns.
According to Blum, these factors suggest a positive reception from physicians and the potential for higher commercial adoption of obe-cel, supporting the optimistic outlook for Autolus Therapeutics plc (NASDAQ:AUTL).
Autolus Therapeutics (NASDAQ:AUTL) is a clinical-stage biopharmaceutical company based in the United Kingdom. It develops programmed T cell therapies for treating autoimmune diseases and cancer, with a focus on chimeric antigen receptor (CAR) T cell therapy.
The company engineers controlled, targeted, and highly active T cell therapy product candidates designed to recognize target cells, break their defense mechanisms down, and eliminate them. It is doing so using a portfolio of proprietary and modular T-cell programming technologies.
While we acknowledge the potential of AUTL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
15 minutes ago
- Boston Globe
Senate Republicans revise Trump's policy bill, scrounging for votes to pass it
Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up Republican leaders in the Senate are rushing to shore up support for the legislation so they can quickly pass it and send it to the House for final approval in time to meet the July 4 deadline Trump has set. An initial vote in the Senate could come later Saturday. Advertisement Party leaders are trying to appease two flanks of their conference. Some, including Sen. Thom Tillis of North Carolina, said they could not support it without greater reassurances that the Medicaid cuts it contains would not hurt rural hospitals in their states. And fiscal hawks, including Sen. Rand Paul of Kentucky, have said they do not want to back legislation that would only increase the deficit. Advertisement The core of the bill remains the same. It would extend tax cuts passed by Republicans in 2017 and add some new ones Trump campaigned on, while slashing spending on safety-net programs, including Medicaid and food assistance. The biggest tax cuts and the biggest changes to those anti-poverty programs remained intact. Taken together, the bill would likely increase federal debt by more than $3 trillion over the next decade, though lawmakers are still shaping the bill and waiting on an official estimate from the Congressional Budget Office. With Trump demanding quick action, Republicans in Congress have intensified their efforts to push it through to enactment even as many of them — including several who voted for it in the House — have been open about their reservations about a measure they are concerned could be a political loser. The revisions released early Saturday were designed to allay some of those concerns. Senators, including Tillis and Susan Collins, R-Maine, had pressed for the inclusion of a rural hospital fund to help health care providers absorb the impact of a provision that would crack down on strategies that many states have developed to finance their Medicaid programs. Despite their pushback, that provider tax change remains in the bill, though lawmakers have delayed its implementation by one year. It is unclear whether a $25 billion compensation fund will be enough to win their votes. Collins had suggested that she wanted to provide as much as $100 billion to ensure that rural hospitals, which operate on thin margins, were not adversely affected. Advertisement But it appeared to be enough to win over at least one Republican holdout who had expressed concern about the Medicaid cuts — Sen. Josh Hawley of Missouri, who said he would vote for the bill and was confident that changes benefit his state at least in the short term. A new provision allowing 'individuals in a noncontiguous state' to be exempt from enforcing new work requirements imposed on SNAP, formerly known as food stamps, appeared aimed at mollifying Murkowski of Alaska. Her state would be hit with billions of dollars in nutrition assistance costs as a result of the legislation, and she had cited the provision as one of her chief concerns. The bill also includes new health provisions designed to benefit Alaska, as well as new tax benefits for fishers in the state's waters. Some of the changes were aimed at appealing to members of the House, where Republicans from high-tax states like New York have threatened to sink the bill if it does not include a substantial increase in the state and local tax deduction, currently capped at $10,000. Senate Republicans, skeptical of the deduction, still ultimately decided to match the House plan to lift the cap to $40,000. But while the House made the increase permanent, the Senate keeps it for only five years, allowing it to snap back to $10,000 in 2030. The newest draft makes even sharper cuts to subsidies for wind and solar power, something that Trump and other conservatives had explicitly called for this past week. It remains to be seen whether those changes could cause friction with Republicans who have publicly supported green energy credits, including Tillis, Murkowski and Sen. John Curtis of Utah. Advertisement Previously, the Senate proposed allowing companies that were building wind and solar farms to claim a tax credit worth at least 30% of their costs if they started construction this year, with a phaseout over two years. But the revised bill would require companies place their projects 'in service' by the end of 2027 to claim the tax break. The bill would also impose additional taxes on renewable energy projects that receive 'material assistance' from China, even if they don't qualify for the credit. Because China dominates global supply chains, those new fees could affect a large number of projects. The new Senate measure would more quickly end tax credits for electric vehicles, doing away with them by Sept. 30. It would also slow the phaseout of a lucrative tax credit to make hydrogen fuels, allowing such projects to qualify if construction were started by the end of 2027, instead of by the end of this year. The bill also includes a provision written by Sen. Mike Lee, R-Utah, to sell as much as 1.225 million acres of federal land across the American West in order to build housing. Earlier versions of that proposal that would have auctioned off even more acreage had drawn fierce opposition from conservative hunters and outdoorsmen, and Republican senators from Montana and Idaho had said they would not vote for it. This article originally appeared in
CNN
19 minutes ago
- CNN
Senate braces for first big vote on Trump agenda – with support still unclear
Senate Republicans are about to face a major test of loyalty to President Donald Trump, as the chamber braces for its first vote on whether to advance the president's giant tax cuts and spending bill. Senate Majority Leader John Thune and his team have been fiercely lobbying their members to get in line behind the measure, with Trump and White House officials also leaning heavily on the remaining GOP holdouts. Trump met with two key holdouts — Sen. Rick Scott of Florida and Ron Johnson of Wisconsin — on Saturday, just hours before GOP leaders hoped to hold the vote, according to those senators' close colleague, Sen. Mike Lee of Utah. He has also spoken to other critical votes, like Sen. Josh Hawley of Missouri, who earlier Saturday declared his support for the bill. Kentucky Sen. Rand Paul, another critic of the bill, golfed with the president on Saturday morning, according to Sen. Lindsay Graham. But it's not yet clear whether Thune will be able to limit defections on a procedural vote, to start centrists like Sen. Thom Tillis and a small group of GOP hardliners — Lee, Scott and Johnson — still pushing for changes to the bill. But GOP leadership believe they will ultimately succeed, thanks, in part, to immense pressure from Trump. Already two Republicans, Tillis and Johnson, have said they would block the bill from moving ahead. That leaves Thune just one more vote to lose. It all amounts to an intense Saturday scramble for Trump and GOP leaders, who are intent on passing the president's agenda as quickly as possible. Trump has told GOP leaders he wants to sign the bill at the White House on July 4 – but that would still require approval from the narrowly divided GOP-controlled House, which is also no guarantee. This story is breaking and will be updated.
Yahoo
19 minutes ago
- Yahoo
Hesai Group (HSAI) Soars 19.26% as New Lidar Secures Safety Certification
Hesai Group (NASDAQ:HSAI) is one of the . Hesai Group soared by 19.26 percent on Thursday to end at $23.10 apiece after achieving a new milestone for its ATX Lidar and safety certification portfolio. In a statement, Hesai Group (NASDAQ:HSAI) said that its ATX, a compact, high-resolution, long-range lidar, officially obtained ISO 26262 ASIL B functional safety certification from SGS-TÜV, the world's leading testing, inspection, and certification institution. ATX marked its fourth ISO 26262 accreditation after after Pandar128, QT128, and AT128. With the new certification, Hesai Group (NASDAQ:HSAI) said it now holds the highest number of ISO 26262 certified products in the world. ISO 26262 is a key standard for the functional safety of electrical and electronic (E/E) systems in vehicles. It calls for carefully planned safety measures at every step of the development process—from safety management and concept design, to system, hardware, and software development. Logistics robots filling packages in a warehouse, preparing for delivery. As vehicles become more dependent on E/E systems, ISO plays an important role in ensuring vehicle components adhere to the most stringent safety standards to reduce costly recalls and prevent passenger injuries. While we acknowledge the potential of HSAI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
